After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
These stocks trading for less than $10 a share look ready to break out and trade higher from current levels.
Titan Pharmaceuticals (TTNP) stock is climbing after the FDA's Psychopharmacologic Drugs Advisory Committee voted in favor of approving the company's treatment for opioid addiction.
These under-$10 biotech stocks are within range of triggering major breakout trades.
Titan and its partner will resubmit Probuphine for FDA approval later this year.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.